Evox Therapeutics Company
Rare metabolic, neuromuscular diseases, DeliverEX platform - exosome technology, exosome based therapies, rare metabolic, neurological, undisclosed.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
2016
Employees Number:
51-100
Funding Status:
Late Stage Venture
Investors Number:
9
Total Funding:
£47.2M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Grant
Register and Claim Ownership